Legal Representation
Attorney
Jong H Park
USPTO Deadlines 2 active
| Deadline Type | Event Code | Deadline Date | Days Until | Priority | Extension Available |
|---|---|---|---|---|---|
|
MAINTENANCE
Section 8 (6-Year) Declaration Due (Based on registration date 2022-07-26) |
R.PR | Jul 26, 2028 | 1115 days | Critical | No |
|
MAINTENANCE
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2022-07-26) |
R.PR | Jul 26, 2032 | 2576 days | Critical | No |
Next deadline: Section 8 (6-Year) Declaration Due (Based on registration date 2022-07-26)
on July 26, 2028
(1115 days)
Application History
32 events| Date | Code | Type | Description |
|---|---|---|---|
| Jul 26, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Jul 26, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| May 10, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION |
| May 10, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Apr 20, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Apr 1, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Mar 21, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Mar 21, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| Mar 21, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Mar 21, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Mar 16, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Mar 16, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Mar 15, 2022 | ALIE | A | ASSIGNED TO LIE |
| Mar 14, 2022 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Feb 15, 2022 | CNSL | R | SUSPENSION LETTER WRITTEN |
| Feb 15, 2022 | GNSL | S | LETTER OF SUSPENSION E-MAILED |
| Feb 15, 2022 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Feb 14, 2022 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Feb 14, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Feb 14, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Aug 19, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Aug 19, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Aug 19, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Aug 12, 2021 | CNSI | R | SUSPENSION INQUIRY WRITTEN |
| Aug 12, 2021 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED |
| Aug 12, 2021 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Feb 12, 2021 | CNSL | R | SUSPENSION LETTER WRITTEN |
| Feb 12, 2021 | GNSL | F | LETTER OF SUSPENSION E-MAILED |
| Feb 12, 2021 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Feb 10, 2021 | DOCK | D | ASSIGNED TO EXAMINER |
| Oct 31, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sep 26, 2020 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of cancer cells; living cells for medical or clinical use; pharmaceutical preparations for activating cellular function; biological preparations for the treatment of immune system related disorders; biological preparations for the treatment of cancer; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for tumor treatment; vaccines; pharmaceutical preparations for the treatment of cancers with T cells; pharmaceutical preparations for the treatment of cancers with CAR-T cells
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005